Literature DB >> 8397091

Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium.

B Musser1, M E Morgan, M Leid, T F Murray, J Linden, R E Vestal.   

Abstract

The antagonist radioligand 1,3-[3H]dipropyl-8-cyclopentylxanthine ([3H]DPCPX) was used to characterize adenosine A1 receptors in membrane preparations from atrial and ventricular myocardium of rat, rabbit, guinea pig and pig. Kd values in crude membranes from guinea pig atria and ventricles (3.3 and 3.0 nM) were higher than those in the other species (ranges, 1.5-1.8 and 1.5-1.9 nM). Bmax values were greater in atria than in ventricles in all four species, and in atria and ventricles of guinea pig (76 and 34 fmol/mg), than in the other species (ranges, 15-17 and undetectable to 12 fmol/mg). In contrast, guinea pig Kd and Bmax values for beta-adrenoceptors, which were labelled with (-)3-[125I]iodocyanopindolol, fell within the range of values for the other three mammalian species. In semipurified membrane preparations from pig, [3H]DPCPX and the agonist radioligand [125I]-N6-4-aminobenzyladenosine appeared to label a similar population of receptors and gave comparable Kd values in atria (0.73 and 0.66 nM) and in ventricles (0.57 and 0.70 nM). In semipurified preparations from pig, the agonist R-(-)-N6-(2-phenylisopropyl)adenosine (R-PIA) displaced [3H]DPCPX in a manner consistent with the presence of both high- and low-affinity adenosine A1 receptors. The data from this study indicate that the density of adenosine A1 receptors in atria is greater than in ventricles, but similar Kd values suggest that the A1 receptor population is the same in the two cardiac tissues. Also, the data demonstrate that the [3H]DPCPX antagonist binding characteristics of guinea pig myocardium differ from those in rat, rabbit and pig.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397091     DOI: 10.1016/0922-4106(93)90086-o

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Differential development of adenosine A1 and A2b receptors in the rat duodenum.

Authors:  J A Peachey; S M Hourani; I Kitchen
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Decreased expression of phospholamban is not associated with lower beta-adrenergic activation in rat atria.

Authors:  A Kaasik; K Paju; A Minajeva; J Ohisalo
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

3.  Partial adenosine A1 receptor agonists for cardiovascular therapies.

Authors:  Barbara E Albrecht-Küpper; Kirsten Leineweber; Peter G Nell
Journal:  Purinergic Signal       Date:  2011-11-12       Impact factor: 3.765

4.  Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury.

Authors:  M Miyamae; I Diamond; M W Weiner; S A Camacho; V M Figueredo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure.

Authors:  Hani N Sabbah; Ramesh C Gupta; Smita Kohli; Mengjun Wang; Sharad Rastogi; Kefei Zhang; Katja Zimmermann; Nicole Diedrichs; Barbara E Albrecht-Küpper
Journal:  Circ Heart Fail       Date:  2013-04-05       Impact factor: 8.790

6.  The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.

Authors:  J A Peachey; S M Hourani; I Kitchen
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 7.  Adenosine and the Cardiovascular System: The Good and the Bad.

Authors:  Régis Guieu; Jean-Claude Deharo; Baptiste Maille; Lia Crotti; Ermino Torresani; Michele Brignole; Gianfranco Parati
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

Review 8.  Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.

Authors:  Marine Gaudry; Donato Vairo; Marion Marlinge; Melanie Gaubert; Claire Guiol; Giovanna Mottola; Vlad Gariboldi; Pierre Deharo; Stéphane Sadrin; Jean Michel Maixent; Emmanuel Fenouillet; Jean Ruf; Regis Guieu; Franck Paganelli
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

Review 9.  Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?

Authors:  Franck Paganelli; Giovanna Mottola; Julien Fromonot; Marion Marlinge; Pierre Deharo; Régis Guieu; Jean Ruf
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.